| 12:30 PM | Prognostic Impact of CHA2DS2-VASc-HS Score on Midterm Clinical Outcomes after Elective PCI for Chronic Coronary Syndrome: A Single-center Retrospective Study Abstract Presenter: Tomoaki Ukaji |
| 12:40 PM | Comparison of Clinical Outcomes After DCB and DES in Very Small Coronary Artery Intervention Abstract Presenter: Cheng-Hsuan Tsai |
| 12:50 PM | Prognostic Impact of Plasma Glucose on Cardiogenic Shock Patients With or Without Diabetes Mellitus: Smart Rescue Trial Abstract Presenter: Seong Huan Choi |
| 1:00 PM | Role of Serum N-6 Polyunsaturated Fatty Acids in the Development of Acute Coronary Syndromes Abstract Presenter: Naoya Inoue |
| 1:10 PM | Effects of High-Sensitivity C-reactive Protein on Lipoprotein(a)-Associated Cardiovascular Mortality Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Abstract Presenter: Deshan Yuan |
| 1:20 PM | Cost-Effectiveness Analysis of High-Potency Versus Low-Potency Statins for Reducing Mortality in Coronary Artery Disease Patients on Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention. Abstract Presenter: Shaban Mohammed |
| 1:30 PM | Annual Operator Volume Among Patients Treated Using Percutaneous Coronary Interventions with Rotational Atherectomy and Procedural Outcomes - Analysis Based on a Large National Registry Abstract Presenter: Rafal Januszek |
| 1:40 PM | Long-Term Safety and Efficacy Outcomes After Treatment of Coronary Artery Lesions Using Sirolimus Coated Balloons: Insights From Real-World All-Comer Patients Abstract Presenter: Sameer Dani |